Amylyx Pharmaceuticals (AMLX) Confirms FDA Approval of RELYVRIO for the Treatment of ALS
Go back to Amylyx Pharmaceuticals (AMLX) Confirms FDA Approval of RELYVRIO for the Treatment of ALS| (NASDAQ: AMLX) | Delayed: 32.41 -1.53 (4.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.94 | 52 Week High | $ | |||
| Open | $34.21 | 52 Week Low | $ | |||
| Day High | $34.21 | P/E | N/A | |||
| Day Low | $32.25 | EPS | $ | |||
| Volume | 2,048,794 | |||||
